Scholarlink

<p>This is an in vitro study aimed to develop a nano-antibiotic paste containing chloramphenicol, tetracycline, and silver and zinc oxide nanoparticles, evaluating its microbiological efficacy against four bacterial strains, determining its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against a commercial CTZ paste. Silver and zinc oxide nanoparticles (1 × 10<sup>− 2</sup> M) were synthesized and characterized by UV-Vis and DLS. A paste of tetracycline and chloramphenicol was prepared to a known concentration (10%), adding the synthesized nanoparticles and reducing the antibiotic percentage from the original proportions (− 4%). The commercial CTZ paste was then prepared following the manufacturer’s instructions (13% concentration). Microdilution method and Kirby-Bauer assessment were used at three different concentrations to evaluate antimicrobial activity for both pastes against <i>Enterococcus faecalis</i>,<i> Staphylococcus aureus</i>,<i> Streptococcus mutans</i>,<i> and Escherichia coli</i>. MBC for the nano antibiotic paste (10%) and commercial CTZ paste (13%) were 4.8&#xa0;µg/ml and 12&#xa0;µg/ml for <i>S. aureus</i>, 19.5&#xa0;µg/ml and 12.8&#xa0;µg/ml for <i>E. coli</i>, 19.5&#xa0;µg/ml and 12.8&#xa0;µg/ml for <i>E. faecalis</i>, 39&#xa0;µg/ml and 25&#xa0;µg/ml for <i>S. mutans</i>, respectively. For Kirby Bauer statistical difference was shown, favoring nano paste for C1 <i>E. coli</i> (<i>p</i> = 0.000262) and C2 <i>E. coli</i> (<i>p</i> = 0.000388), and for C3 <i>S. mutans</i> (<i>p</i> = 0.00749), and commercial CTZ paste, for C2 <i>S. aureus</i> (<i>p</i> = 0.0146) and C2 <i>E. faecalis</i> (<i>p</i> = 0.00033). Microbiological assays revealed that the commercial CTZ de Mexico™ paste (13%) exhibited superior bactericidal activity, with lower MBCs, than the Nano formulation (10%) containing 4% less antibiotic. Results offer in vitro doses for the strains.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development of a nano antibiotic paste for lesion sterilization and tissue repair technique in pediatric dentistry

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月29日

查看全文
  • Daniela Guzmán Uribe,
  • Idania De Alba Montero,
  • Gabriel Alejandro Martínez Castañón,
  • Facundo Ruiz,
  • Nereyda Niño Martínez

摘要

This is an in vitro study aimed to develop a nano-antibiotic paste containing chloramphenicol, tetracycline, and silver and zinc oxide nanoparticles, evaluating its microbiological efficacy against four bacterial strains, determining its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against a commercial CTZ paste. Silver and zinc oxide nanoparticles (1 × 10− 2 M) were synthesized and characterized by UV-Vis and DLS. A paste of tetracycline and chloramphenicol was prepared to a known concentration (10%), adding the synthesized nanoparticles and reducing the antibiotic percentage from the original proportions (− 4%). The commercial CTZ paste was then prepared following the manufacturer’s instructions (13% concentration). Microdilution method and Kirby-Bauer assessment were used at three different concentrations to evaluate antimicrobial activity for both pastes against Enterococcus faecalis, Staphylococcus aureus, Streptococcus mutans, and Escherichia coli. MBC for the nano antibiotic paste (10%) and commercial CTZ paste (13%) were 4.8 µg/ml and 12 µg/ml for S. aureus, 19.5 µg/ml and 12.8 µg/ml for E. coli, 19.5 µg/ml and 12.8 µg/ml for E. faecalis, 39 µg/ml and 25 µg/ml for S. mutans, respectively. For Kirby Bauer statistical difference was shown, favoring nano paste for C1 E. coli (p = 0.000262) and C2 E. coli (p = 0.000388), and for C3 S. mutans (p = 0.00749), and commercial CTZ paste, for C2 S. aureus (p = 0.0146) and C2 E. faecalis (p = 0.00033). Microbiological assays revealed that the commercial CTZ de Mexico™ paste (13%) exhibited superior bactericidal activity, with lower MBCs, than the Nano formulation (10%) containing 4% less antibiotic. Results offer in vitro doses for the strains.